Systemic underfunding of mental healthcare drives misinformation campaigns against antidepressants, perpetuating stigma and policy failures
Original framing: “RFK Jr. plans to curb antidepressants, which he falsely compares to heroin” — Ars Technica
The deinstitutionalization movement of the 1960s-70s, driven by cost-cutting and anti-psychiatry critiques, left millions without adequate care, creating the conditions for today's overreliance on pharmaceuticals. The 1980s shift toward neoliberal healthcare policies further privatized mental health services, while pharmaceutical companies exploited regulatory loopholes to market SSRIs for off-label uses. The opioid crisis itself emerged from similar structural failures, where corporate greed and policy neglect turned a medical tool into a public health disaster. RFK Jr.'s rhetoric echoes historical anti-psychiatry movements, which often conflated legitimate critiques with pseudoscientific fearmongering.
The controversy over RFK Jr.
's anti-antidepressant rhetoric reveals a deeper crisis in mental healthcare: a system that oscillates between pharmaceutical overreliance and ideological rejection of medication, both of which serve to obscure structural failures. Indigenous and cross-cultural perspectives demonstrate that depression is not merely a chemical imbalance but a symptom of disrupted harmony—whether with land, community, or spirit—yet these frameworks are systematically excluded from policy debates. The historical arc of deinstitutionalization and neoliberal healthcare privatization created the conditions for today's polarized discourse, where corporate lobbies and anti-regulation movements exploit public distrust to dismantle what little remains of public mental health infrastructure. A systemic solution requires not just debunking misinformation but reimagining care through decolonized, community-centered models that address root causes rather than symptoms. The trickster's role here is not to mock but to expose the absurdity of a system that profits from both the overuse and the vilification of antidepressants, while failing to provide holistic, accessible alternatives.